Selected Publications
- Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6). Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva, Joseph A. Murray. Archives of Dermatological Research
- Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients. Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva, Joseph A. Murray. Archives of Dermatological Research
- Tape Strip Profiling of Checkpoint Inhibitor–Associated Dermatitis Highlights Pan-T-Cell Activation: A Pilot Study. Camille M. Powers, Madeline Kim, Annie Chang, Benjamin D. Hu, Brandon R. Block, Austin J. Piontkowski, Jeremy Orloff, Jade N. Young, Yeriel D. Estrada, Digpal S. Gour, Emma Guttman-Yassky, Nicholas Gulati. JID Innovations